Numinus Wellness Inc.

The Analyst Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE: IWIN) (OTC: IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 “on adjusted estimates.” The Thesis Zuanic highlighted the “potential approval...

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022. "Fiscal 2022 was a...

Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide this treatment outside of a clinical trial. The newly approved treatment will be...

June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF). That day, shareholders will vote in two special meetings on the proposed acquisition of Novamind by Numinus. This week both companies shared circulars with their shareholders, asking them to...

Field Trip Psychedelics Inc. announced Tuesday the successful synthesis of FT-104, a novel compound that is believed to have psychedelic capabilities. The conclusion comes after in-vitro and in-vivo tests confirmed that FT-104 interacts with the 5HT2A receptor, which is the main antagonist targeted...

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. New Leaf Brands Changes Name To Mydecine, Announces New HQ  Cannabis company NewLeaf...